Special Issue "Plant-Derived Pharmaceuticals by Molecular Farming 2016"
Тезисы до: 30.08.2016
Даты: 30.08.16 — 30.08.16
Е-мейл Оргкомитета: firstname.lastname@example.org
Организаторы: International Journal of Molecular Sciences
чMolecular farming (MF), in terms of production scale and economy, product safety, ease of storage, and distribution, is superior to any other current commercial alternative. Despite MF’s promising benefits, the commercialization of MF-derived products is lagging behind due to uncertainty and safety issues. A particularly troubling issue concerns the adaptation of good manufacturing practice regulations for transgenic organisms. Although MF is not yet routinely commercialized, interest and investment in MF are extending rapidly. Ultimately, MF will progress and become a core commercial development in biotechnology.
This Special Issue aims to provide high quality research concerning a novel gene expression in target organisms, such as green algae or plants, and the utilization of this technique to manufacture pharmaceutical proteins. Possible MF products include biopharmaceuticals, nutraceuticals, vaccines, metabolites, and foreign proteins for industrial purposes. Possible topics cover research in MF’s industrial and preclinical/clinical applications, or MF’s environmental impacts. I wish to thank all authors for their contributions to this Special Issue.
Веб-сайт конференции: http://www.mdpi.com/journal/ijms/special_issues/farming_2016